Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria

Proceedings of the National Academy of Sciences of the United States of America

Volumn 115, Issue 8, 2018, Pages 1895-1900

  Vågesjö, Evelina ^a   Öhnstedt, Emelie ^a   Mortier, Anneleen ^b   Lofton, Hava ^a   Huss, Fredrik ^a,c   Proost, Paul ^b   Roos, Stefan ^d   Phillipson, Mia ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Blood flow; Chemokine; Diabetes; Lactobacillus reuteri; Macrophage

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; LACTIC ACID; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENGINEERING; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG STABILITY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOCOMPETENT CELL; LACTIC ACID BACTERIUM; MACROPHAGE; MOUSE; NONHUMAN; PERIPHERAL ISCHEMIA; PH; PLASMID; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SKIN CELL; WOUND CLOSURE; WOUND HEALING; ANIMAL; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; INJURY; LACTOBACILLUS REUTERI; METABOLISM; SKIN; TISSUE CULTURE TECHNIQUE;

ANIMALS; CELL PROLIFERATION; CHEMOKINE CXCL12; GENE EXPRESSION REGULATION; GENETIC THERAPY; HUMANS; LACTOBACILLUS REUTERI; MACROPHAGES; MICE; PLASMIDS; SKIN; TISSUE CULTURE TECHNIQUES; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING; WOUNDS AND INJURIES;

EID: 85042175062     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1716580115     Document Type: Article

References (42)

1. Gurtner GC, Werner S, Barrandon Y, Longaker MT (2008) Wound repair and regeneration. Nature 453:314–321.
2. Bianchi ME (2007) DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 81:1–5.
3. Orlova VV, et al. (2007) A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J 26:1129–1139.
4. Sozzani S, et al. (1995) Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol 155:3292–3295.
5. Phillipson M, Kubes P (2011) The neutrophil in vascular inflammation. Nat Med 17:1381–1390.
6. Badillo AT, Chung S, Zhang L, Zoltick P, Liechty KW (2007) Lentiviral gene transfer of SDF-1alpha to wounds improves diabetic wound healing. J Surg Res 143:35–42.
7. Feng G, Hao D, Chai J (2014) Processing of CXCL12 impedes the recruitment of endothelial progenitor cells in diabetic wound healing. FEBS J 281:5054–5062.
8. Bollag WB, Hill WD (2013) CXCR4 in epidermal keratinocytes: Crosstalk within the skin. J Invest Dermatol 133:2505–2508.
9. Boniakowski AE, Kimball AS, Jacobs BN, Kunkel SL, Gallagher KA (2017) Macrophage-mediated inflammation in normal and diabetic wound healing. J Immunol 199:17–24.
10. Beider K, et al. (2014) Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype. Oncotarget 5:11283–11296.
11. Sánchez-Martín L, et al. (2011) The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. Blood 117:88–97.
12. Bootun R (2013) Effects of immunosuppressive therapy on wound healing. Int Wound J 10:98–104.
13. Goren I, et al. (2009) A transgenic mouse model of inducible macrophage depletion: Effects of diphtheria toxin-driven lysozyme m-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. Am J Pathol 175:132–147.
14. Lucas T, et al. (2010) Differential roles of macrophages in diverse phases of skin repair. J Immunol 184:3964–3977.
15. Demidova-Rice TN, Hamblin MR, Herman IM (2012) Acute and impaired wound healing: Pathophysiology and current methods for drug delivery, part 1: Normal and chronic wounds: Biology, causes, and approaches to care. Adv Skin Wound Care 25:304–314.
16. Poetker DM, Reh DD (2010) A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol Clin North Am 43:753–768.
17. Lipsky BA, et al.; Infectious Diseases Society of America (2012) 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 54:e132–e173.
18. Demidova-Rice TN, Hamblin MR, Herman IM (2012) Acute and impaired wound healing: Pathophysiology and current methods for drug delivery, part 2: Role of growth factors in normal and pathological wound healing: Therapeutic potential and methods of delivery. Adv Skin Wound Care 25:349–370.
19. Kuliszewski MA, Kobulnik J, Lindner JR, Stewart DJ, Leong-Poi H (2011) Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle. Mol Ther 19:895–902.
20. Yamaguchi J, et al. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107:1322–1328.
21. Mortier A, Gouwy M, Van Damme J, Proost P, Struyf S (2016) CD26/dipeptidylpeptidase IV-chemokine interactions: Double-edged regulation of inflammation and tumor biology. J Leukoc Biol 99:955–969.
22. Baticic Pucar L, Pernjak Pugel E, Detel D, Varljen J (2017) Involvement of DPP IV/ CD26 in cutaneous wound healing process in mice. Wound Repair Regen 25:25–40.
23. Saboo A, Rathnayake A, Vangaveti VN, Malabu UH (2016) Wound healing effects of dipeptidyl peptidase-4 inhibitors: An emerging concept in management of diabetic foot ulcer-A review. Diabetes Metab Syndr 10:113–119.
24. Ohtsuki T, et al. (1998) Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/ dipeptidyl peptidase IV. FEBS Lett 431:236–240.
25. Proost P, et al. (1998) Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha. FEBS Lett 432:73–76.
26. Velnar T, Bailey T, Smrkolj V (2009) The wound healing process: An overview of the cellular and molecular mechanisms. J Int Med Res 37:1528–1542.
27. Nakamura Y, Ishikawa H, Kawai K, Tabata Y, Suzuki S (2013) Enhanced wound healing by topical administration of mesenchymal stem cells transfected with stromal cell-derived factor-1. Biomaterials 34:9393–9400.
28. Zhu Y, et al. (2016) Sustained release of stromal cell derived factor-1 from an antioxidant thermoresponsive hydrogel enhances dermal wound healing in diabetes. J Control Release 238:114–122.
29. Wood S, et al. (2014) Pro-inflammatory chemokine CCL2 (MCP-1) promotes healing in diabetic wounds by restoring the macrophage response. PLoS One 9:e91574.
30. Segers VFM, et al. (2011) Protease-resistant stromal cell-derived factor-1 for the treatment of experimental peripheral artery disease. Circulation 123:1306–1315.
31. Hu MS, et al. (2017) Delivery of monocyte lineage cells in a biomimetic scaffold enhances tissue repair. JCI Insight 2:96260.
32. Devalaraja RM, et al. (2000) Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol 115:234–244.
33. Yager DR, Nwomeh BC (1999) The proteolytic environment of chronic wounds. Wound Repair Regen 7:433–441.
34. Marfella R, et al. (2012) Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes. Exp Diabetes Res 2012:892706.
35. Gao Z, Tseng CH, Pei Z, Blaser MJ (2007) Molecular analysis of human forearm superficial skin bacterial biota. Proc Natl Acad Sci USA 104:2927–2932.
36. Qiu ZB, et al. (2013) Effect of recombinant Lactobacillus casei expressing interleukin-10 in dextran sulfate sodium-induced colitis mice. J Dig Dis 14:76–83.
37. Loera-Arias MJ, et al. (2014) Secretion of biologically active human interleukin 22 (IL-22) by Lactococcus lactis. Biotechnol Lett 36:2489–2494.
38. Lambeir AM, et al. (2001) Kinetic investigation of chemokine truncation by CD26/ dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem 276:29839–29845.
39. Eming SA, Wynn TA, Martin P (2017) Inflammation and metabolism in tissue repair and regeneration. Science 356:1026–1030.
40. Wynn TA, Vannella KM (2016) Macrophages in tissue repair, regeneration, and fibrosis. Immunity 44:450–462.
41. Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: Enabling diversity with identity. Nat Rev Immunol 11:750–761.
42. Mahdavian Delavary B, van der Veer WM, van Egmond M, Niessen FB, Beelen RHJ (2011) Macrophages in skin injury and repair. Immunobiology 216:753–762.